In July 2014, Fund IX and affiliates invested approximately $318 million to acquire Healogics Holding Corp., the largest hospital outsourced wound care services provider in the United States. The transaction was valued at approximately $910 million, before transaction fees and expenses. Operating Advisor John Dineen serves as Chairman of the business.

In July 2014, CD&R Fund IX and affiliates invested $330 million to acquire Mauser Group, a global leader in industrial packaging. The transaction was valued at approximately €1.17 billion before transaction fees and expenses. Operating Partner Vindi Banga serves as Chairman of the business.

In June 2015, Fund IX and affiliates agreed to acquire Motor Fuel Group, the second largest independent petrol and convenience retail operator in the U.K., in partnership with management. Fund IX will invest approximately $226 million. The transaction is expected to close in July.

In August 2014, CD&R Fund IX and affiliates invested $405 million to acquire Solenis (formerly known as Ashland Water Technologies) from Ashland Inc. The transaction was valued at approximately $1.8 billion. Operating Advisor John Ballbach serves as Chairman of the business.

In January 2014, CD&R Fund IX and affiliates invested $343 million to acquire PharMEDium Healthcare Corporation, the leading provider of hospital pharmacy-outsourced sterile compounding services. The transaction was valued at approximately $950 million, including transaction fees and expenses. Operating Advisor Ron Williams serves as Chairman of the business.

In July 2015, Fund IX and affiliates invested $40 million in Vets First Choice, the leading provider of cloud-based prescription management, pharmacy services, marketing solutions, and business analytics for veterinary practitioners nationwide.